Bank of Nova Scotia
BMY icon

Bank of Nova Scotia’s Bristol-Myers Squibb BMY Stock Holding History

Bank of Nova Scotia’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-350,000
Closed -$20.7M – 1207
2021
Q3 		$20.7M Buy
+350,000
New +$23M 0.04% 352

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Nova Scotia's BMY Position: Q1 2026 in Review

Bank of Nova Scotia reduced its Bristol-Myers Squibb (BMY) stake by 6.3% in Q1 2026, selling an estimated $2.94M and leaving 752,756 shares worth $45.7M. The position accounts for 0.08% of the portfolio, ranked #183.

Bank of Nova Scotia first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $190M in Q2 2020. 2,526 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Bank of Nova Scotia held 752,756 shares of Bristol-Myers Squibb worth $45.7M as of Q1 2026.
  • Bank of Nova Scotia sold 50,416 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.94M.
  • Bristol-Myers Squibb made up 0.08% of Bank of Nova Scotia's portfolio in Q1 2026, its #183 holding.
  • Bank of Nova Scotia first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Bank of Nova Scotia's Bristol-Myers Squibb position peaked at $190M in Q2 2020.
  • 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.